|
Terri Wilder
Twenty-Seven Years of Women Living With HIV: Past, Present and Future
January 1, 2008
2003. The National Institutes of Health releases the press statement titled, "Nevirapine Sustains Advantage Over AZT During Breastfeeding Period." The press release goes on to describe how infants who receive a single does of the inexpensive drug nevirapine soon after birth -- and whose mothers took one dose of the same drug during labor -- were 41 percent less likely to acquire HIV at birth or during breastfeeding than infants in infant/mother pairs who were treated with a multi-dose regimen using AZT. Anthony Fauci states, "This landmark study could have far-reaching implications in resource-poor countries where breastfeeding and mother-to-child HIV transmission are both common."
This article was provided by Terri Wilder. It is a part of the publication Twenty-Seven Years of Women Living With HIV: Past, Present and Future. |